Liang‐Nian Ji
- Oncology top 0.2%
- Molecular Biology top 1%
- Organic Chemistry top 0.2%
- Materials Chemistry top 1%
- Biomedical Engineering top 0.5%
- Co-authors
- Hui ChaoZong‐Wan MaoCai‐Ping TanLeli ZengQianling ZhangJinquan WangPingyu ZhangZhe‐Sheng Chen
- Topics
- Metal complexes synthesis and properties (120 papers)DNA and Nucleic Acid Chemistry (58 papers)Porphyrin and Phthalocyanine Chemistry (44 papers)
- Journals
- Journal of the American Chemical SocietyChemical Society ReviewsAngewandte Chemie International Edition
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Liang‐Nian Ji
249 papers receiving 12.0k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Oncology 5.9k
- Molecular Biology 4.5k
- Organic Chemistry 4.4k
- Materials Chemistry 3.8k
- Biomedical Engineering 2.8k
Countries citing papers authored by Liang‐Nian Ji
This map shows the geographic impact of Liang‐Nian Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang‐Nian Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang‐Nian Ji more than expected).
Fields of papers citing papers by Liang‐Nian Ji
This network shows the impact of papers produced by Liang‐Nian Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang‐Nian Ji. The network helps show where Liang‐Nian Ji may publish in the future.
Co-authorship network of co-authors of Liang‐Nian Ji
This figure shows the co-authorship network connecting the top 25 collaborators of Liang‐Nian Ji. A scholar is included among the top collaborators of Liang‐Nian Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang‐Nian Ji. Liang‐Nian Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 23 | |
| 2 | 11 | |
| 3 | 18 | |
| 4 | 120 | |
| 5 | 24 | |
| 6 | 15 | |
| 7 | 114 | |
| 8 | 2 | |
| 9 | The development of anticancer ruthenium( | 876 |
| 10 | 56 | |
| 11 | 141 | |
| 12 | 78 | |
| 13 | 41 | |
| 14 | 116 | |
| 15 | 45 | |
| 16 | 85 | |
| 17 | 20 | |
| 18 | 7 | |
| 19 | 3 | |
| 20 | 13 |
About Liang‐Nian Ji
Liang‐Nian Ji is a scholar working on Oncology, Inorganic Chemistry and Organic Chemistry, having authored 250 papers that have together received 12.1k indexed citations. Recurring topics across this work include Metal complexes synthesis and properties (120 papers), DNA and Nucleic Acid Chemistry (58 papers) and Porphyrin and Phthalocyanine Chemistry (44 papers). The work is most often cited by research in Oncology (5.9k citations), Organic Chemistry (4.4k citations) and Inorganic Chemistry (1.5k citations). Liang‐Nian Ji has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Hui Chao, Zong‐Wan Mao, Cai‐Ping Tan, Leli Zeng, Qianling Zhang, Jinquan Wang, Pingyu Zhang, Zhe‐Sheng Chen, Yu Chen and Jin‐Gang Liu. Their work appears in journals such as Journal of the American Chemical Society, Chemical Society Reviews and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.